EVH NYSE
Evolent Health, Inc.
1W: -9.2%
1M: +21.1%
3M: +33.9%
YTD: +13.6%
1Y: -43.4%
3Y: -83.5%
5Y: -84.9%
$4.42
-0.11 (-2.43%)
Pre-Market: $4.59 (+0.17, +3.85%)
Weekly Expected Move ±9.7%
$4
$4
$5
$5
$6
Credit Risk of going bust: higher than 91% of companies Debt: 66.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the riskiest tenth, about 1 in 20 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.81 (down 82%), Evolent Health, Inc. would be worth roughly what it owes.
Total debt $970.4M against a stock market value of $497.2M.
Distance to default 1.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $483.2M (short-term plus half of long-term), stock volatility 80.1%; Altman Z'' -3.10. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.81 (down 82%), Evolent Health, Inc. would be worth roughly what it owes.
Total debt $970.4M against a stock market value of $497.2M.
Distance to default 1.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $483.2M (short-term plus half of long-term), stock volatility 80.1%; Altman Z'' -3.10. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
13 relationships13
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-06-29
Earliest Filing
2025-02-04
Latest Filing
partner: 5
target: 4
acquirer: 2
investor: 2
Counterparties (Filed by EVH)
13 relationshipsCompanies named in EVH's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Engaged Capital, LLC | — | partner | Entered into a Cooperation Agreement with Evolent Health, Inc. to appoint a director and establish voting guidelines. | 2025-02-04 | View |
| Engaged Capital Flagship Master Fund, LP | — | partner | Signatory to the Cooperation Agreement with Evolent Health, Inc. | 2025-02-04 | View |
| Engaged Capital Co-Invest XI-B, LP | — | partner | Signatory to the Cooperation Agreement with Evolent Health, Inc. | 2025-02-04 | View |
| Engaged Capital Holdings, LLC | — | partner | Signatory to the Cooperation Agreement with Evolent Health, Inc. | 2025-02-04 | View |
| Magellan Health, Inc. | MGLN | target | Target company acquired in the Magellan Specialty Health Division transaction. | 2023-01-23 | View |
| Magellan Parent | — | target | Parent company of the target business unit sold to Evolent Health. | 2023-01-23 | View |
| Magellan Health, Inc. | MGLN | acquirer | Target company in the acquisition of National Imaging Associates and Magellan Specialty Health Division assets. | 2022-11-17 | View |
| Magellan Healthcare, Inc. | — | acquirer | Target company in the acquisition of National Imaging Associates and Magellan Specialty Health Division assets. | 2022-11-17 | View |
| TPG Growth Iceman Parent | — | investor | Investor in the merger and equityholder receiving Class A shares | 2022-08-02 | View |
| TPG Growth V Iceman | — | investor | Representative for TPG Growth Iceman Parent in the merger agreement | 2022-08-02 | View |
| TPG Growth Iceman Parent, Inc. | — | target | Target company in the merger agreement with Evolent Health, Inc. | 2022-06-29 | View |
| Implantable Provider Group, Inc. | — | target | Parent entity of the target company in the merger agreement. | 2022-06-29 | View |
| TPG Growth V Iceman, L.P. | — | partner | Representative for the target company in the merger agreement. | 2022-06-29 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-06-04 | Shareholder Vote | View | |
| 2026-05-07 | Earnings Release; Exhibits | View | |
| 2026-02-24 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-08 | Other Events | View | |
| 2025-12-02 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-09-23 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-21 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-08-19 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-18 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-20 | Entry into Material Definitive Agreement; Regulation FD Disclosure; Other Events; Financial Statemen | Agreement | View |
| 2025-06-05 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-06-03 | Regulation FD Disclosure | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-22 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Financial Statem | View | |
| 2025-02-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-04 | Entry into Material Definitive Agreement; Departure/Election of Directors; Appointment of Officers; | Agreement | View |
| 2025-01-30 | Creation of Direct Financial Obligation | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR